Effectiveness of Cognitive Behavioural Therapy for Insomnia (CBT-I) in Individuals With Neurodevelopmental Conditions: A Systematic Review
Abstract
Cognitive Behavioural Therapy for insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia disorder in diverse populations with co-occurring conditions. However, individuals with neurodevelopmental conditions are frequently excluded from CBT-I research, despite the high prevalence of sleep problems in this population. The present systematic review and narrative synthesis investigates the effectiveness of CBT-I in individuals with neurodevelopmental conditions. A literature search was completed in February 2024 across five databases. Of 1988 unique entries, 8 studies from 5 countries met all inclusion criteria, amounting to a combined sample size of 598 participants (male = 75.92%, age range = 4-68). Five interventions were delivered to children and adolescents (M = 8.7 years ±1.46), whilst 3 were delivered to adults (M = 35.78 years ±5.71). All interventions included at least 2 CBT-I components but were diverse in content and format. Two randomised controlled trials and six before-after studies suggested significant short-term effectiveness of CBT-I in individuals with Autism Spectrum Disorder (ASD) and/or Attention-Deficit/Hyperactivity Disorder (ADHD). Improvements in the severity of condition-specific characteristics were observed in some studies. Still, findings were inconsistent and mostly not maintained at follow-up. The quality of included articles was moderate due to small sample sizes, lack of blinding and deviations from the intended…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 598 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.